Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STRIDER Canada: A Randomized Controlled Trial of Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction (Canada)

NCT02442492 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT02442492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02442492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STRIDER Canada: A Randomized Controlled Trial of Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction (Canada)
Lead sponsor
University of British Columbia
Phase
Phase 2/3
Overall status
Terminated
Start date
January 31, 2017
Completion date
April 30, 2019
Enrollment
21 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth restriction (fgr), intrauterine growth restriction (iugr)